This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...

After a preliminary announcement a few weeks ago that included a CEO change, CVS Health CVS released its full third-quarter ...

Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsDavid Joyner - President, Chief ...

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.

CVS Caremark said it used historical claims ... The consolidation that has combined health insurers with pharmacy benefit managers — including their operating their own retail, mail-order and ...

In the drug store and pharmacy retail segment ... drugstores remain a leading shopping destination for consumers. CVS Health is well-positioned to maintain its relevance and continue thriving ...